Tag Archives: comparative effectiveness

PCORI Initiatives May Support More Drug Comparisons

The Patient-Centered Outcomes Research Institute (PCORI) is launching new programs that are expected to encourage more analysis of the effectiveness of specific drugs and medical products, while also building infrastructure that could support clinical research on biopharmaceutical products. Since it was established by the 2010 health reform legislation, PCORI has  devoted much of its resources […]
Posted in R&D, Regulatory | Also tagged , , , , , , , , | Leave a comment

For What it’s Worth: Study Probes Evolving Value Schemes

PharmaFutures’ Pathways to Value: Pharma in a Changing World explains how the industry may move forward to combine business imperatives and social mandates through new strategies for determining value and reimbursement for medicines. The study determines that collaboration across three fronts is needed to ensure that value is recognized and adapted over time, taking into […]
Posted in Emerging Markets, Europe, Market Access, pricing, R&D, Regulatory, Strategy | Also tagged , , , , , , | Leave a comment

Beating the Comparative Effectiveness Drum: Keeping Time with the National Pharmaceutical Council

Celebrating its 60th year, the National Pharmaceutical Council (NPC) has played a key role in defining and enacting solutions to some of pharma’s most pressing issues. NPC is not a formal trade association, nor is it an academic think tank, its mandate lies somewhere in between. Now, it is committed to a specific focus on […]
Posted in R&D, Regulatory, Strategy, Technology | Also tagged , , , | Leave a comment

PCORI Launches Clinical Research Network to Support Trials, Outcomes Research

The new National Patient-Centered Clinical Research Network funded by the Patient-Centered Outcomes Research Institute (PCORI) aims to provide patients and clinicians with useful information on treatment options and outcomes. By encouraging more comparative clinical effectiveness research (CER),  the program also has potential to support development of new drugs and devices, explained PCORI executive director Joe […]
Posted in FDA, healthcare | Also tagged , , , , , , , , , , , , , | Leave a comment

New Roster of Players to Debate Comparative Effectiveness Standards

Methodologies are the heart of any consistent approach to certifying comparative effectiveness for new medicines—semantics aside, it’s the way payers and providers are going to determine clinical “value” and, by subtle extrapolation, their cost against existing alternative therapies. Last week, the Patient Centered Outcomes Research Institute [PCORI] created through federal health reform legislation moved one […]
Posted in healthcare, People, pricing, Regulatory | Also tagged , , | Leave a comment
  • Categories

  • Meta